1. A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study. (January 2020) Authors: Chiang, Nai-Jung; Tsai, Kelvin K.; Hsiao, Chin-Fu; Yang, Shih-Hung; Hsiao, Hui-Hua; Shen, Wen-Chi; Hsu, Chiun; Lin, Yu-Lin; Chen, Jen-Shi; Shan, Yan-Shen; Chen, Li-Tzong Journal: European journal of cancer Issue: Volume 124(2020) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors. Issue 1 (December 2016) Authors: Chiang, Nai-Jung; Chao, Tsu-Yi; Hsieh, Ruey-Kuen; Wang, Cheng-Hsu; Wang, Yi-Wen; Yeh, C.; Chen, Li-Tzong Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial. Issue 3 (January 2016) Authors: Chen, Ming-Huang; Lin, Johnson; Hsiao, Chin-Fu; Shan, Yan-Shen; Chen, Yeu-Chin; Chen, Li-Tzong; Liu, Tsang-Wu; Li, Chung-Pin; Chao, Yee Other Names: Wall. Patrick section editor. Journal: Medicine Issue: Volume 95:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial. Issue 3 (January 2016) Authors: Chen, Ming-Huang; Lin, Johnson; Hsiao, Chin-Fu; Shan, Yan-Shen; Chen, Yeu-Chin; Chen, Li-Tzong; Liu, Tsang-Wu; Li, Chung-Pin; Chao, Yee Editors: Wall., Patrick Journal: Medicine Issue: Volume 95:Issue 3(2016) Page Start: e2565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study. (September 2022) Authors: Bai, Li-Yuan; Li, Chung-Pin; Shan, Yan-Shen; Chuang, Shih-Chang; Chen, Jen-Shi; Chiang, Nai-Jung; Chen, Yen-Yang; Tsou, Hsiao-Hui; Chuang, Mei-Hsing; Chiu, Chang-Fang; Liu, Tsang-Wu; Chen, Li-Tzong Journal: European journal of cancer Issue: Volume 173(2022) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study. Issue 10 (October 2021) Authors: Valle, Juan W; Vogel, Arndt; Denlinger, Crystal S; He, Aiwu Ruth; Bai, Li-Yuan; Orlova, Rashida; Van Cutsem, Eric; Adeva, Jorge; Chen, Li-Tzong; Obermannova, Radka; Ettrich, Thomas J; Chen, Jen-Shi; Wasan, Harpreet; Girvan, Allicia C; Zhang, Wei; Liu, Jiangang; Tang, Chunlao; Ebert, Philip J; Agg... Journal: Lancet oncology Issue: Volume 22:Issue 10(2021) Page Start: 1468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Adjuvant therapy in biliary tract cancers: oral fluoropyrimidine as a beginning. Issue 10372 (21st January 2023) Authors: Chiang, Nai-Jung; Chen, Li-Tzong Journal: Lancet Issue: Volume 401:Issue 10372(2023) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator. Issue 4 (21st January 2012) Authors: Wu, Li-Ching; Chen, Li-Tzong; Tsai, Yueh-Ju; Lin, Chun-Mao; Lin, Ching-Yih; Tian, Yu-Fang; Sheu, Ming-Juen; Uen, Yih-Huei; Shiue, Yow-Ling; Wang, Yu-Hui; Yang, Shu-Jing; Wu, Wen-Ren; Li, Shau-Hsuan; Iwamuro, Masaya; Kobayasshi, Naoya; Huang, Hsuan-Ying; Li, Chien-Feng Journal: Journal of clinical pathology Issue: Volume 65:Issue 4(2012) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials. Issue 4 (5th April 2022) Authors: Kang, Yoon-Koo; Reck, Martin; Nghiem, Paul; Feng, Yan; Plautz, Gregory; Kim, Hye Ryun; Owonikoko, Taofeek K; Boku, Narikazu; Chen, Li-Tzong; Lei, Ming; Chang, Han; Lin, Wen Hong; Roy, Amit; Bello, Akintunde; Sheng, Jennifer Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation. Issue 9 (2nd September 2015) Authors: Tsai, Hui-Jen; Shih, Neng-Yao; Kuo, Sung-Hsin; Cheng, Ann-Lii; Lin, Hui-You; Chen, Tsai-Yun; Chang, Kung-Chao; Lin, Sheng-Fung; Chang, Jeffrey S.; Chen, Li-Tzong Journal: Leukemia & lymphoma Issue: Volume 56:Issue 9(2015:Sep.) Page Start: 2674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗